期刊文献+

外周血KIM-1在肝硬化合并肝肾综合征患者中的表达及意义 被引量:3

The expression and significance of of peripheral KIM-1 levels for early hepatorenal syndrome patients
下载PDF
导出
摘要 目的通过分析肝硬化合并肝肾综合征(HRS)患者外周血肾损伤因子-1(KIM-1)水平,探讨KIM-1的早期诊断、预测价值。方法选择肝硬化患者60例(单纯肝硬化患者35例,肝硬化合并HRS患者25例),选择健康体检者30例作对照,比较不同组患者Scr、BUN、eGRF、KIM-1和血清Cys-C水平,分析KIM-1诊断HRS的ROC曲线以及KIM-1水平与Cys-C、Scr和eGRF的相关性。结果随着Child-Pugh分级的上升,患者Scr、BUN、KIM-1和Cys-C水平增高,eGRF水平降低,差异有统计学意义(P<0.05)。合并HRS组患者KIM-1和Cys-C水平均高于单纯肝硬化组,差异有统计学意义(P<0.001)。KIM-1诊断HRS的AUC为0.808(P<0.05)。肝硬化患者血清KIM-1水平与Cys-C、Scr呈正相关;与eGRF呈负相关。结论外周血KIM-1水平能够比较灵敏地反映肝硬化合并肝肾综合征患者的早期肾损害,对其早期诊断、预测有重要的临床价值。 Objective By analyzing the peripheral kidney injury molecule-1 levels of patients with hepatorenal syndrome,to explore the early diagnosis and predictive value of KIM-1.Methods 60 patients of liver cirrhosis (35 patients with cirrhosis alone,25 patients with liver cirrhosis complicated HRS)were selected,and 30 cases of healthy people were selected as control group,Scr,BUN,eGRF,KIM-1 and Cys-C levels were compared in different groups,the ROC curve of KIM-1 diagnosis on HRS patients,correlation analysis of KIM-1 levels and Cys-C,Scr and eGRF were conducted.Results With the rise of the Child-Pugh classification,Scr,BUN,KIM-1 and Cys-C levels increased,and eGRF level reduced,the difference was statistically significant (P 〈0.05).The KIM-1 and Cys-C levels in combined HRS group were higher than those in cirrhosis group,the difference was statistically significant (P 〈0.001).The AUC of KIM-1 diagnosis on HRS was 0.808 (P 〈0.05).Serum KIM-1 and Cys-C,Scr were positively correlated;KIM-1 and eGRF were negative correlated.Conclusion Peripheral blood KIM-1 level is a sensitive response indicator of early renal damage in patients with hepatorenal syndrome,and it has important clinical value for early diagnosis and prediction.
出处 《中国实验诊断学》 2015年第5期751-753,共3页 Chinese Journal of Laboratory Diagnosis
关键词 肝硬化 肝肾综合征 肾损伤因子-1 liver cirrhosis hepatorenal syndrome kidney injury molecule-1
  • 相关文献

参考文献9

二级参考文献47

  • 1骆健峰,龚永生.尾加压素Ⅱ研究新进展[J].国外医学(内科学分册),2005,32(1):10-13. 被引量:4
  • 2RL Mehta,JA Kellum,S Shah,B Molitoris,C Ronco,D Warnock,A Levin,王欣.急性肾损伤诊断与分类专家共识[J].中华肾脏病杂志,2006,22(11):661-663. 被引量:352
  • 3姚于泓,陈慎仁,李恩民.中性粒细胞明胶酶相关脂质运载蛋白与肾脏疾病[J].实用医学杂志,2007,23(6):925-927. 被引量:19
  • 4王海燕.肾脏病学[M].北京:人民卫生出版社,2008:1948-1949.
  • 5王海燕.肾脏病临床概览[M].北京:北京大学医学出版社,2010:40-47.
  • 6Kramer AB,van Timmeren MM,Schuurs TA,et al.Reduction of pro-teinuria in adriamycin-induced nephropathy is associated with reduc-tion of renal kidney injury molecule(Kim-1)over time[J].Am J Physiol Renal Physiol,2009,296(5):F1136-F1145.
  • 7Ichimura T,Hung CC,Yang SA,et al.Kidney injury molecule-1:a tissue and urinary biomarker for nephrotoxicant-induced renal injury[J].Am J Physiol Renal Physiol,2004,286(3):F552-F563.
  • 8SALERNO F, GERBES A, GINES P, et al. Diagnosis, pre?vention and treatment of hepatorenal syndrome in cirrhosis[J]. Gut, 2007,56(9): 1310 -1318.
  • 9COULOUAM Y, LlTU - MEMN I,JEGOU S, et al. Cloning of eDNA encoding the urotensin n precurmr in frog and human reveals intense expression of the urotensin n gene in moto?neurons of the spinal cord[J]. Prec Natl Acad Sci USA, 1998,95(26): 158 -163.
  • 10HELLERJ, SCHEPKE M, NEFF M, et al. Increased uroten?sin II plasma levels in patients with cirrhosis and portal hyper?tension[J].J Hepatol, 2002, 37 (6) : 767 - 772.

共引文献24

同被引文献24

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部